Q32 Bio
QTTB
QTTB
72 hedge funds and large institutions have $406M invested in Q32 Bio in 2024 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 19 increasing their positions, 8 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
7.98% more ownership
Funds ownership: 67.55% → 75.53% (+8%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
72
Holding in Top 10
3
Calls
$4K
Puts
–
Top Buyers
| 1 | +$18M | |
| 2 | +$11M | |
| 3 | +$8.48M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.56M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$4.77M |
Top Sellers
| 1 | -$4.52M | |
| 2 | -$4.12M | |
| 3 | -$1.96M | |
| 4 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
-$1.01M |
| 5 |
EAM
Exome Asset Management
New York
|
-$787K |